As shown in Figure 5B, dasatinib-DNA Au-NPs targeting the human BIRC5 mRNA, but not a scrambled control, significantly inhibit the proliferation of dasatinib-sensitive leukemia cell lines. Here, BIRC5 is linked to leukemia.